Literature DB >> 32097928

Parotidectomy via Individualized Mini-Blair Incision.

Avi Khafif1, Assadi Niddal1, Ofer Azoulay1, Victoria Holostenco1, Muhamed Masalha2,3.   

Abstract

BACKGROUND: The modified Blair incision is the standard facial incision for the vast majority of parotid gland lesions. We utilize three types of incisions: "classic mini-Blair" for parotid body tumors, "cervical mini-Blair" for parotid tail tumors, and "vertical mini-Blair" for anterior parotid tumors. In this study, we describe the surgical and esthetic outcomes of these individually tailored incisions.
METHODS: Patients undergoing parotidectomy between 2011 and 2013 were included. The surgical outcomes and patients' satisfaction were assessed.
RESULTS: Of 122 patients, 89 were included. All patients completed a questionnaire assessing the postoperative course and patients' satisfaction regarding the surgery in general and the scar in particular. Among these patients, 78 (87%) had a benign pathology and 11 (13%) had malignant tumors. The tumors were located at the parotid body in 57 patients (64%), at the parotid tail in 19 (21%), at the deep lobe in 8 (9%), and at the anterior parotid gland in 5 (6%). All tumors were removed successfully with negative margins on pathology. No inadvertent permanent facial nerve paralysis occurred. The median operation time was 72 min (23-211). The average patient scores of satisfaction with the surgical scar and with the surgery were 9.54 and 9.72, respectively.
CONCLUSIONS: Individualized mini-Blair incision is feasible for benign as well as selected malignant parotid tumors.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Cosmetic result; Facial nerve; Mini-Blair incision; Parotid

Mesh:

Year:  2020        PMID: 32097928     DOI: 10.1159/000505192

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  1 in total

1.  Excising Parotid Benign Mass With a Minimal Incision.

Authors:  Fayez A A Alrohaimi; Muath Abuhaimed; Homood M Almutairi
Journal:  Cureus       Date:  2022-02-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.